Recent developments in the field of inhibitors of the Na+/H+ exchanger.
This review focuses on compounds with Na+/H+ exchanger inhibitory activity and their clinical potential in ameliorating ischemia/reperfusion injury related to cardiovascular indications.
Kleeman
H W
HW
Hoechst Marion Roussel Deutschland GmbH, Medicinal Chemistry, Building G 838, 65926 Frankfurt, Germany. andreas.weichert@hmrag.com
Weichert
A G
AG